Given its role as a key regulator of neutrophil production, release and function, we propose that careful targeting of the G‐CSF pathway could prevent excessive neutrophil activation during CPB and reduce postoperative morbidity and mortality from SIRS. This evidence concerns the gene CSF3 and systemic inflammatory response syndrome.